Drozitumab (PRO 95780) is an agonistic human monoclonal antibody targeting the death receptor DR5. It demonstrates significant antitumor efficacy against rhabdomyosarcoma [1] [2] [3].
Molecular Weight:
143.1 (kDa)
CAS Number:
[912628-39-8]
* VAT and and shipping costs not included. Errors and price changes excepted
